Laboratory for Joint Tissue Repair and Regeneration, Orthopedic Soft Tissue Research Program, Hospital for Special Surgery, New York, New York, USA.
Department of Cartilage Regeneration, Graduate School, Tokyo Medical and Dental University, Tokyo, Japan.
Am J Sports Med. 2019 Sep;47(11):2596-2607. doi: 10.1177/0363546519865513. Epub 2019 Aug 6.
Artificial meniscal scaffolds are being developed to prevent development of osteoarthritis after meniscectomy. Previously, it was reported that 3-dimensional (3D) anatomic scaffolds loaded with connective tissue growth factor (CTGF) and transforming growth factor β3 (TGF-β3) achieved meniscal regeneration in an ovine model. This was a relatively short-term study (3 months postoperative), and outcome analyses did not include magnetic resonance imaging (MRI).
To evaluate long-term outcome of meniscal replacement with growth factor-laden poly-ε-caprolactone (PCL) scaffolds.
Controlled laboratory study.
Anatomically shaped ovine meniscal scaffolds were fabricated from PCL with a 3D printer based on MRI data. Skeletally mature sheep (N = 34) were randomly allocated to 3 groups: scaffold without growth factor (0-µg group), scaffold with CTGF microspheres (µS) (5 µg) + TGF-β3 µS (5 µg) (5-µg group), and scaffold with CTGF µS (10 µg) + TGF-β3 µS (10 µg) (10-µg group). Unilateral medial meniscal replacement was performed. Animals were euthanized at 6 or 12 months. Regenerated meniscus, articular cartilage status, and synovial reaction were evaluated quantitatively with gross inspection, histology, and MRI. Kruskal-Wallis and Dunn tests were used to compare the 3 groups.
Remnants of the PCL scaffold were evident in the 6-month specimens and were decreased but still present at 12 months in most animals. There were no significant differences among groups in gross inspection, histology, or MRI for either meniscal regeneration or articular cartilage protection. All experimental groups exhibited articular cartilage degeneration as compared with control (nonoperated). In terms of synovitis, there were no clear differences among groups, suggesting that growth factors did not increase inflammation and fibrosis. MRI revealed that meniscal extrusion was observed in most animals (82.7%).
Previously, the combination of CTGF and TGF-β3 was shown to stimulate mesenchymal stem cells into a fibrochondrocyte lineage. CTGF and TGF-β3 did not aggravate synovitis, suggesting no adverse response to the combination of 3D-printed PCL scaffold combined with CTGF and TGF-β3. Further work will be required to improve scaffold fixation to avoid meniscal extrusion.
A significant advantage of this technique is the ability to print custom-fit scaffolds from MRI-generated templates. In addition, average-size menisci could be printed and available for off-the-shelf applications. Based on the 1-year duration of the study, the approach appears to be promising for meniscal regeneration in humans.
人工半月板支架的开发是为了防止半月板切除术后骨关节炎的发展。此前有报道称,三维(3D)解剖支架负载连接组织生长因子(CTGF)和转化生长因子β3(TGF-β3)可在羊模型中实现半月板再生。这是一项相对短期的研究(术后 3 个月),并且结果分析不包括磁共振成像(MRI)。
评估生长因子负载聚己内酯(PCL)支架的半月板置换的长期结果。
对照实验室研究。
根据 MRI 数据,使用 3D 打印机从 PCL 制造出解剖形状的羊半月板支架。将成熟的羊(N=34)随机分配到 3 组:无生长因子支架(0-μg 组)、载 CTGF 微球(5μg)+TGF-β3 微球(5μg)支架(5-μg 组)和载 CTGF 微球(10μg)+TGF-β3 微球(10μg)支架(10-μg 组)。进行单侧内侧半月板置换。动物在 6 或 12 个月时安乐死。通过大体检查、组织学和 MRI 定量评估再生半月板、关节软骨状况和滑膜反应。使用 Kruskal-Wallis 和 Dunn 检验比较 3 组。
在 6 个月的标本中,PCL 支架的残留物仍然存在,并且在大多数动物中,12 个月时减少,但仍然存在。在半月板再生或关节软骨保护方面,各组之间的大体检查、组织学或 MRI 均无显著差异。与对照组(未手术)相比,所有实验组均出现关节软骨退变。就滑膜炎而言,各组之间没有明显差异,这表明生长因子并没有增加炎症和纤维化。MRI 显示,大多数动物(82.7%)出现半月板外突。
此前,CTGF 和 TGF-β3 的组合被证明可以刺激间充质干细胞向纤维软骨细胞谱系分化。CTGF 和 TGF-β3 并未加重滑膜炎,这表明 3D 打印 PCL 支架与 CTGF 和 TGF-β3 结合没有不良反应。需要进一步工作来改善支架固定以避免半月板外突。
该技术的一个显著优势是能够从 MRI 生成的模板打印定制支架。此外,还可以打印平均大小的半月板,并提供现货应用。根据研究的 1 年持续时间,该方法似乎有望在人类半月板再生中得到应用。